NCT06492148 Myofascial Release Technique in Women With Primary Dysmenorrhea
| NCT ID | NCT06492148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gazi University |
| Condition | Dysmenorrhea Primary |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-09-10 |
| Primary Completion | 2024-12-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-09-10 with a primary completion date of 2024-12-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide, * Having regular menstruation in the last 6 months (28±7 days) * Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months Exclusion Criteria: * Diagnosed with Secondary Dysmenorrhea, * Having given birth, * Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes, * Undergoing urogynecological surgery, * Those who are pregnant or suspected of pregnancy, * Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain, * Those using intrauterine or oral contraceptives, * Those taking extra supplements such as magnesium, which may affect treatment
Contact & Investigator
Beyza Yazgan Dagli
PRINCIPAL INVESTIGATOR
Gazi University
Frequently Asked Questions
Who can join the NCT06492148 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Dysmenorrhea Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06492148 currently recruiting?
Yes, NCT06492148 is actively recruiting participants. Contact the research team at beyzayazgan@gazi.edu.tr for enrollment information.
Where is the NCT06492148 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06492148 clinical trial?
NCT06492148 is sponsored by Gazi University. The principal investigator is Beyza Yazgan Dagli at Gazi University. The trial plans to enroll 36 participants.